Artificial intelligence is changing how clinical genomics is practiced. From variant prioritization to phenotype matching and report generation, AI helps geneticists and molecular biologists focus their expertise where it matters most, while keeping every decision transparent and traceable.
In this section, you will find our articles on AI in clinical genomics: how explainable AI supports variant interpretation, what labs should look for when evaluating AI-powered bioinformatics platforms, and how SeqOne applies machine learning to accelerate diagnosis without turning analysis into a black box.

GermVar PGx, the first module of SeqOne Preventive Genomics, supports laboratories with pharmacogenomic analysis inside the germline workflow, from star-allele calling to the guideline recommendations their experts review and report.

Valencia’s General University Hospital brought HRD testing in-house with Agilent and SeqOne. A 30-case study showed matching classifications vs. commercial assays, fewer inconclusive results, and turnaround cut from ~20 to 6-7 days.

SomaHRD v2 reaches 97.1% concordance with Myriad MyChoice CDx and a PFS hazard ratio of 0.23, with a 4.8% non-conclusive rate and results in 41 minutes.

Rewatch our webinar with Uppsala University Hospital: how one lab unified short-read, long-read, and array workflows on a single platform, and how transparent AI ranks variants so the geneticist stays in control.